Literature DB >> 26064450

Molecular and functional significance of Ca(2+)-activated Cl(-) channels in pulmonary arterial smooth muscle.

Normand Leblanc1, Abigail S Forrest1, Ramon J Ayon2, Michael Wiwchar1, Jeff E Angermann3, Harry A T Pritchard4, Cherie A Singer1, Maria L Valencik5, Fiona Britton6, Iain A Greenwood4.   

Abstract

Increased peripheral resistance of small distal pulmonary arteries is a hallmark signature of pulmonary hypertension (PH) and is believed to be the consequence of enhanced vasoconstriction to agonists, thickening of the arterial wall due to remodeling, and increased thrombosis. The elevation in arterial tone in PH is attributable, at least in part, to smooth muscle cells of PH patients being more depolarized and displaying higher intracellular Ca(2+) levels than cells from normal subjects. It is now clear that downregulation of voltage-dependent K(+) channels (e.g., Kv1.5) and increased expression and activity of voltage-dependent (Cav1.2) and voltage-independent (e.g., canonical and vanilloid transient receptor potential [TRPC and TRPV]) Ca(2+) channels play an important role in the functional remodeling of pulmonary arteries in PH. This review focuses on an anion-permeable channel that is now considered a novel excitatory mechanism in the systemic and pulmonary circulations. It is permeable to Cl(-) and is activated by a rise in intracellular Ca(2+) concentration (Ca(2+)-activated Cl(-) channel, or CaCC). The first section outlines the biophysical and pharmacological properties of the channel and ends with a description of the molecular candidate genes postulated to encode for CaCCs, with particular emphasis on the bestrophin and the newly discovered TMEM16 and anoctamin families of genes. The second section provides a review of the various sources of Ca(2+) activating CaCCs, which include stimulation by mobilization from intracellular Ca(2+) stores and Ca(2+) entry through voltage-dependent and voltage-independent Ca(2+) channels. The third and final section summarizes recent findings that suggest a potentially important role for CaCCs and the gene TMEM16A in PH.

Entities:  

Keywords:  TMEM16A; anoctamin; bestrophin; calcium-activated chloride channels; pulmonary hypertension

Year:  2015        PMID: 26064450      PMCID: PMC4449236          DOI: 10.1086/680189

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  279 in total

1.  Multiple conductance states of single Ca2+-activated Cl- channels in rabbit pulmonary artery smooth muscle cells.

Authors:  A S Piper; W A Large
Journal:  J Physiol       Date:  2003-01-10       Impact factor: 5.182

2.  Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane.

Authors:  Vladimir M Milenkovic; Andrea Rivera; Franziska Horling; Bernhard H F Weber
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

3.  Characteristics of chloride currents activated by noradrenaline in rabbit ear artery cells.

Authors:  T Amédée; W A Large; Q Wang
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

4.  Studies on expression and function of the TMEM16A calcium-activated chloride channel.

Authors:  Fen Huang; Jason R Rock; Brian D Harfe; Tong Cheng; Xiaozhu Huang; Yuh Nung Jan; Lily Yeh Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

5.  Identification of an N-terminal amino acid of the CLC-3 chloride channel critical in phosphorylation-dependent activation of a CaMKII-activated chloride current.

Authors:  N C Robinson; P Huang; M A Kaetzel; Fred S Lamb; D J Nelson
Journal:  J Physiol       Date:  2004-01-30       Impact factor: 5.182

Review 6.  Inositol 1,4,5-trisphosphate receptors as signal integrators.

Authors:  Randen L Patterson; Darren Boehning; Solomon H Snyder
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

7.  Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel.

Authors:  Ricardo De La Fuente; Wan Namkung; Aaron Mills; A S Verkman
Journal:  Mol Pharmacol       Date:  2007-12-14       Impact factor: 4.436

8.  Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation.

Authors:  Michele Sweeney; Ying Yu; Oleksandr Platoshyn; Shen Zhang; Sharon S McDaniel; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-07       Impact factor: 5.464

9.  STIM1, an essential and conserved component of store-operated Ca2+ channel function.

Authors:  Jack Roos; Paul J DiGregorio; Andriy V Yeromin; Kari Ohlsen; Maria Lioudyno; Shenyuan Zhang; Olga Safrina; J Ashot Kozak; Steven L Wagner; Michael D Cahalan; Gönül Veliçelebi; Kenneth A Stauderman
Journal:  J Cell Biol       Date:  2005-05-02       Impact factor: 10.539

10.  Activation and inhibition of TMEM16A calcium-activated chloride channels.

Authors:  Yu-Li Ni; Ai-Seon Kuan; Tsung-Yu Chen
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

View more
  13 in total

Review 1.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

2.  Molecular mechanism of TMEM16A regulation: role of CaMKII and PP1/PP2A.

Authors:  Ramon J Ayon; Matthew B Hawn; Joydeep Aoun; Michael Wiwchar; Abigail S Forrest; Fiona Cunningham; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

Review 3.  Molecular pathogenesis and current pathology of pulmonary hypertension.

Authors:  Vinicio A de Jesus Perez
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

4.  Permeation Mechanisms in the TMEM16B Calcium-Activated Chloride Channels.

Authors:  Simone Pifferi
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 5.  Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?

Authors:  Mélanie Lambert; Véronique Capuano; Andrea Olschewski; Jessica Sabourin; Chandran Nagaraj; Barbara Girerd; Jason Weatherald; Marc Humbert; Fabrice Antigny
Journal:  Int J Mol Sci       Date:  2018-10-14       Impact factor: 5.923

6.  Increased intracellular Cl- concentration in pulmonary arterial myocytes is associated with chronic hypoxic pulmonary hypertension.

Authors:  Hui Sun; Omkar Paudel; James S K Sham
Journal:  Am J Physiol Cell Physiol       Date:  2021-06-23       Impact factor: 5.282

7.  Targeting TMEM16A-encoded Ca2+-activated Cl- channels: a new paradigm for antihypertensive therapy?

Authors:  Normand Leblanc
Journal:  Kidney Int       Date:  2021-08       Impact factor: 18.998

Review 8.  TMEM16A: An Alternative Approach to Restoring Airway Anion Secretion in Cystic Fibrosis?

Authors:  Henry Danahay; Martin Gosling
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

9.  Oroxylin A Reduces Vasoconstriction in Rat Aortic Rings through Promoting NO Production and NOS Protein Expression via Estrogen Receptor Signal Pathway.

Authors:  Jingtian Qu; Fang Liu; Xuezhu Zhang; Jialong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-30       Impact factor: 2.629

10.  A paradoxical increase of force development in saphenous and tail arteries from heterozygous ANO1 knockout mice.

Authors:  Vladimir V Matchkov; Henrik Black Joergensen; Dmitrii Kamaev; Andreas Hoegh Jensen; Hans Christian Beck; Boris V Skryabin; Christian Aalkjaer
Journal:  Physiol Rep       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.